96
Participants
Start Date
March 20, 2025
Primary Completion Date
November 30, 2033
Study Completion Date
August 1, 2036
Imatinib
imatinib treatment based on molecular alterations
Trametinib
According to biomarkers
Dabrafenib
According to biomarkers
RECRUITING
Oslo University Hospital, Oslo
Helse Stavanger HF
OTHER_GOV
University Hospital of North Norway
OTHER
StOlavs Hospital
UNKNOWN
Nordlandssykehuset HF
OTHER
Helse Nord-Trøndelag HF
OTHER
Sorlandet Hospital HF
OTHER_GOV
Møre og Romsdal Hospital Trust
OTHER
The Hospital of Vestfold
OTHER
Helse Fonna
OTHER
Haukeland University Hospital
OTHER
Sykehuset Ostfold
OTHER
Helse Forde
OTHER
Sykehuset Innlandet HF
OTHER
Oslo University Hospital
OTHER